Femring Side Effects
View Community-reported Femring side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Femring Side Effect
Have You dealt with a Femring side effect? Share your experience
Femring Side Effects summary
Total Femring reports: 22.Femring FDA safety alerts: No.
Reported hospitalizations: 11.
Take Femring Side Effects Survey, Discuss Femring with others
Femring Side Effects: breast tenderness, ovarian cyst, vaginal haemorrhage, metrorrhagia, hydrometra, vulvovaginal mycotic infection, upper respiratory tract infection, menopausal symptoms, disease recurrence, chest pain, procedural pain,
Femring Usage.
If you have questions about Femring, you can ask a Health Expert or Ask Patient Community about Femring.
Femring Side Effects reported to FDA
Femring Side Effects Report #5663427-6
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Feb 22, 2008. Female patient, 45 years of age, weighting 158.1 lb, was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, abdominal distension, abdominal tenderness, alanine aminotransferase increased, aphasia, balance disorder, blood glucose increased, breast tenderness, confusional state. FEMRING dosage: .05 MG, QD, VAGINAL. During the same period patient was treated with CENESTIN, FLEXERIL, IMITREX. Patient recovered.
Femring Side Effects Report #5623826-5
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2008. Female patient, 45 years of age, weighting 158.1 lb, was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, abdominal distension, abdominal pain, abdominal tenderness, alanine aminotransferase increased, anorexia, aphasia, balance disorder, blood glucose increased. FEMRING dosage: 0.05 MG,QD; VAGINAL. During the same period patient was treated with CENESTIN, FLEXERIL, IMITREX. Patient recovered.
Femring Side Effects Report #5590591-X
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Dec 27, 2007. Female patient was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, abdominal distension, abdominal pain, abdominal tenderness, anorexia, aphasia, balance disorder, breast tenderness. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with CENESTIN. Patient recovered.
Femring Side Effects Report #5604271-5
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Female patient, 53 years of age, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: endometrial disorder, ovarian cyst, vaginal candidiasis. FEMRING dosage: 0.05MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5564726-9
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Nov 29, 2007. Female patient was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, abdominal distension, abdominal tenderness, anorexia, aphasia, balance disorder, breast tenderness, confusional state, decreased appetite. FEMRING dosage: 0.05MG, QD, VAGINAL. During the same period patient was treated with CENESTIN. Patient recovered.
Femring Side Effects Report #5489147-9
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2007. Female patient, 34 years of age, weighting 115.1 lb, was diagnosed with vulvovaginal discomfort, vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: anxiety, autonomic nervous system imbalance, chest pain, decreased appetite, depression, disease recurrence, dizziness, hormone level abnormal. FEMRING dosage: 0.1 MG, QD, VAGINAL; 0.1 MG, QD, VAGINAL. During the same period patient was treated with LIPITOR, CARDIZEM, PREMARIN, REMERON. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5504042-4
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Oct 18, 2007. Female patient, 34 years of age, weighting 115.1 lb, was diagnosed with vulvovaginal discomfort, vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: chest pain, heart rate irregular, hormone level abnormal, hot flush, loss of consciousness, medical device complication, night sweats. FEMRING dosage: 0.1 MG, QD, VAGINAL. During the same period patient was treated with NADOLOL, LIPITOR, CARDIZEM, PREMARIN. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5449522-5
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Female patient, 40 years of age, weighting 119.9 lb, was diagnosed with artificial menopause and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: disease recurrence, rheumatoid arthritis, vulvovaginal mycotic infection. FEMRING dosage: 0.1 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID. Patient recovered.
Femring Side Effects Report #5379555-9
Consumer or non-health professional from UNITED STATES reported FEMRING problem on June 20, 2007. Female patient, 56 years of age, weighting 194.9 lb, was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: histoplasmosis, medical device complication, pneumonia, procedural pain, skeletal injury. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID, ACIPHEX, VALIUM, CLONIDINE, BUPROPION, LIPITOR, BONIVA, MIRALAX. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5392986-6
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2007. Female patient, 72 years of age, weighting 153.9 lb, was diagnosed with vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: biopsy cervix abnormal, chest pain, dizziness, fatigue, feeling abnormal, heart rate irregular, ovarian cyst, throat irritation, uterine enlargement. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with AMIODARONE, ASPIRIN, HYZAAR, IMDUR, LOPRESSOR, LUNESTA, NITROSTAT, ZANTAC. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5379555-9
Consumer or non-health professional from UNITED STATES reported FEMRING problem on June 20, 2007. Female patient, 56 years of age, weighting 194.9 lb, was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: histoplasmosis, medical device complication, pneumonia, procedural pain, skeletal injury. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID, ACIPHEX, VALIUM, CLONIDINE, BUPROPION, LIPITOR, BONIVA, MIRALAX. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5392986-6
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2007. Female patient, 72 years of age, weighting 153.9 lb, was diagnosed with vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: biopsy cervix abnormal, chest pain, dizziness, fatigue, feeling abnormal, heart rate irregular, ovarian cyst, throat irritation, uterine enlargement. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with AMIODARONE, ASPIRIN, HYZAAR, IMDUR, LOPRESSOR, LUNESTA, NITROSTAT, ZANTAC. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5348678-2
Consumer or non-health professional from UNITED STATES reported FEMRING problem on May 24, 2007. Female patient, 49 years of age, weighting 175.0 lb, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: disease recurrence, hysterectomy, menopausal symptoms, upper respiratory tract infection. FEMRING dosage: 0.05 MG, QD, VAGINAL RING. During the same period patient was treated with CYMBALTA, PREVACID, PREDNISONE, ALPRAZOLAM, HYDROCODONE, PERCOCET. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5366191-3
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 49 years of age, weighting 175.0 lb, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: menopausal symptoms, upper respiratory tract infection. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with CYMBALTA, PREVACID, PREDNISONE, ALPRAZOLAM, HYDROCODONE, PERCOCET. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5330199-4
Consumer or non-health professional from UNITED STATES reported FEMRING problem on May 02, 2007. Female patient, 61 years of age, weighting 138.0 lb, was diagnosed with menopause and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: breast swelling, breast tenderness, glaucoma. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with CABERGOLINE. Patient recovered.
Femring Side Effects Report #5341169-4
FEMRING problem was reported by a Physician from UNITED STATES on May 17, 2007. Female patient, 38 years of age, weighting 127.0 lb, was diagnosed with hot flush and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: angioedema, chest pain, tachycardia. FEMRING dosage: unknown. During the same period patient was treated with EFFEXOR, NEXIUM, ZYRTEC. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5347891-8
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Apr 24, 2006. Female patient, 54 years of age, weighting 130.1 lb, was diagnosed with hot flush, night sweats, vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: uterine cancer, uterine haemorrhage, uterine leiomyoma, vaginal haemorrhage. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with WELLBUTRIN. Patient recovered.
Femring Side Effects Report #5347894-3
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Female patient, 61 years of age, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: breast cancer. FEMRING dosage: unknown. During the same period patient was treated with PREMARIN. Patient recovered.
Femring Side Effects Report #5347896-7
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Dec 19, 2006. Female patient, 43 years of age, weighting 136.9 lb, was diagnosed with urinary tract infection and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, headache, panic attack, sleep disorder, vaginal haemorrhage. FEMRING dosage: unknown. Patient recovered.
Femring Side Effects Report #5291472-1
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2007. Female patient, 58 years of age, weighting 115.1 lb, was diagnosed with pruritus genital, vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: cystitis interstitial, pruritus genital, vulvovaginal dryness, weight decreased. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID, ESTRADIOL, PROMETRIUM, PROTONIX, PREMARIN. Patient recovered.
Femring Side Effects Report #5291499-X
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Mar 22, 2007. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with menopause and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: breast tenderness, hydrometra, metrorrhagia, ovarian cyst, therapeutic response unexpected. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with WELLBUTRIN. Patient recovered.
Femring Side Effects Report #5303017-8
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Female patient, 56 years of age, weighting 158.1 lb, was diagnosed with vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dyspnoea, hiatus hernia, medical device complication, ovarian cyst, procedural pain, thyroid disorder. FEMRING dosage: 0.05 MG, QD; VAGINAL. During the same period patient was treated with SYNTHROID, DIOVAN HCT, PREVACID, NEXIUM, VITAMIN, FISH OIL, POTASSIUM, CALCIUM. Patient was hospitalized. Patient recovered.